Questcor Pharmacueticals (QCOR) Slammed 34% On Reports Aetna Insurance Coverage Dropped
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Questcor Pharmaceuticals (QCOR) Slammed after Citron Notes Aetna Drops Acthar Coverage
September 19, 2012 10:13 AM EDTQuestcor Pharmaceuticals, Inc. (NASDAQ: QCOR) is seeing downside after Citron Research notes that Aetna (NYSE: AET) is dropping coverage of key drug Acthar.
According to Cintron:
One of the largest managed care providers in the... More
